Slater P E, Roitman M, Costin C
Department of Epidemiology, Ministry of Health, Jerusalem, Israel.
Public Health Rev. 1990;18(4):307-17.
In the Western world, Haemophilus influenzae type b is an important cause of morbidity and long-term disability in children. The availability of vaccines capable of preventing H. influenzae type b disease in very young infants stimulated this longitudinal observational review of the epidemiology of H. influenzae type b meningitis in Israel, based on cases reported to the Ministry of Health in the decade 1981-90.
In the last decade, H. influenzae type b accounted for 884 cases of meningitis, making it the main cause of bacterial meningitis in children. Almost all cases were in children under the age of 5 years, the great majority under 18 months. Age-standardized incidence rates were the same in Jews and in non-Jews, and in both sectors incidence was slightly higher in males than in females. The case fatality rate was 3.3%.
The new Haemophilus b conjugate vaccines are reported to be safe, effective at an early age, and compatible with current vaccination schedules. Their availability means that control of invasive disease caused by this organism is within reach. Use of the vaccines in infants should be encouraged and their effect on morbidity patterns should be closely monitored.
在西方世界,b型流感嗜血杆菌是导致儿童发病和长期残疾的重要原因。能够预防极幼龄婴儿感染b型流感嗜血杆菌疾病的疫苗的出现,促使基于1981 - 1990年这十年间向卫生部报告的病例,对以色列b型流感嗜血杆菌脑膜炎的流行病学进行了这项纵向观察性综述。
在过去十年中,b型流感嗜血杆菌导致了884例脑膜炎病例,使其成为儿童细菌性脑膜炎的主要病因。几乎所有病例都发生在5岁以下儿童中,绝大多数在18个月以下。年龄标准化发病率在犹太人和非犹太人中相同,且在两个群体中男性发病率均略高于女性。病死率为3.3%。
据报道,新型b型流感嗜血杆菌结合疫苗安全、在幼年有效且与当前疫苗接种计划兼容。它们的出现意味着对由该病原体引起的侵袭性疾病的控制指日可待。应鼓励在婴儿中使用这些疫苗,并密切监测其对发病模式的影响。